Used as a key intermediate in the synthesis of fluoroquinolone antibiotics, particularly in the production of advanced pharmaceutical agents with enhanced antimicrobial activity. Its structure supports the development of drugs targeting DNA gyrase and topoisomerase IV, making it valuable in combating resistant bacterial strains. The compound’s fluorinated core improves bioavailability and metabolic stability in final drug formulations. It is also employed in research for developing new central nervous system agents due to its ability to cross the blood-brain barrier.